Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Conception XR is a branded oral male fertility nutritional supplement product line developed and manufactured by Theralogix for men planning to conceive. It is not a pharmaceutical drug or biologic, but a multi-ingredient nutraceutical composed of vitamins, minerals, and related nutrients intended to support sperm quality and male reproductive health. The Reproductive Health formulation includes antioxidant and micronutrient support such as vitamins C and E, zinc, selenium, and methylated folate, while the Motility Support formulation adds 1,000 mg of L-carnitine and additional vitamin D3 to support sperm motility. Its intended effect is nutritional support of spermatogenesis, sperm morphology, and function rather than target-specific pharmacology, and it is manufactured in the USA in a GMP-compliant facility with NSF content certification.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Conception XR.